News
Neuralink said on social media that it received FDA breakthrough device designation for treating individuals with severe ...
(Reuters) -Neuralink has received the U.S. Food and Drug Administration's "breakthrough" tag for its device to restore ...
Colorized transmission electron micrograph of influenza A/H1N1 virus particles. The U.S. Department of Health and Human Services (HHS) and the National Institutes for Health (NIH) today announced the ...
If the FDA deems Pfizer’s and Moderna’s updated vaccines “new” products, it’s extremely unlikely the doses would be ready for ...
A new study analyzed how often people develop severe side effects after taking semaglutide — known by brand names Ozempic and ...
On March 31, 2025, the U.S. District Court for the Eastern District of Texas ruled that the Food and Drug Administration (FDA ...
Treating hidradenitis suppurativa is complex and often requires taking a number of medications, including antibiotics, ...
The top US health department plans to require placebo testing for all vaccines in an effort to offer "straightforward" public ...
Teen nicotine pouch use nearly doubled from 2023 to 2024, raising health concerns and calls for targeted prevention and ...
The US Department of Health and Human Services said Thursday that it aims to accomplish within four years a scientific feat ...
The FDA plans to phase out eight artificial food dyes by the end of 2026 after Robert F. Kennedy has vocally opposed them.
Adult and pediatric generalized myasthenia gravis patients have a new, longer acting option for treatment called Imaavy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results